Not checkedNot checked for notices yet.

Better cardiovascular outcomes of type 2 diabetic patients treated with GLP-1 receptor agonists versus DPP-4 inhibitors in clinical practice

Enrico Longato, Barbara Di Camillo, Giovanni Sparacino and 3 more

Cardiovascular Diabetology · 2020

doi:10.1186/s12933-020-01049-w (opens in a new tab)

We email you when a new notice or a question about this paper appears.

References45

27.
Corrected
GLP-1RAs in type 2 diabetes: mechanisms that underlie cardiovascular effects and overview of cardiovascular outcome data · 2018
28.
Global, Regional, and Country-Specific Lifetime Risks of Stroke, 1990 and 2016 · 2018
36.
Cardiovascular outcomes in trials of new antidiabetic drug classes: a network meta-analysis · 2019

37 more references, whose wording the paper’s licence keeps private.

All 45 references

Cited by papers we hold1

Cardiovascular and renal outcomes with SGLT-2 inhibitors versus GLP-1 receptor agonists in patients with type 2 diabetes mellitus and chronic kidney disease: a systematic review and network meta-analysis · 2021

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.